Rhabdomyosarcoma
RecruitingStudy of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
- Disease:Rhabdomyosarcoma
- Substances:Vincristine SulfateVinorelbine Tartrate
Norway- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Vincristine Sulfate
- Sponsor:The University Of Birmingham









